Population Characteristics and Prognostic Factors in Metastatic Non–Small-Cell Lung Cancer: A Fox Chase Cancer Center Retrospective
Authors:
- Vikram R. ParalkarVPVikram R. Paralkar
- Tianyu LiTLTianyu Li
- Corey J. LangerCLCorey J. Langer
- 1 March 2008
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 9 (2) , 116-121
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung CancerNew England Journal of Medicine, 2006
- A prognostic model for advanced stage nonsmall cell lung cancerCancer, 2006
- Changes in the natural history of nonsmall cell lung cancer (NSCLC)—Comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990Cancer, 2006
- Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group DataJournal of Clinical Oncology, 2005
- Lung Cancer in US WomenJAMA, 2004
- The Noninvasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- Prognostic Factors in Non-small Cell Lung CancerChest, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.Journal of Clinical Oncology, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958